Covered recipient · General Payments record
YAZAN FADI FARAH MADANAT
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$34,833.82
- Reported across 44 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $5,185.00 | 3 |
| Honoraria | $2,156.00 | 1 |
| Food and Beverage | $532.06 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $2,845.00 | 2 |
| TAIHO ONCOLOGY, INC. | $2,340.00 | 1 |
| Blueprint Medicines Corporation | $2,156.00 | 1 |
| ABBVIE INC. | $219.19 | 3 |
| Celgene Corporation | $146.41 | 2 |
| Rigel Pharmaceuticals, Inc. | $97.18 | 1 |
| Tempus AI, Inc | $51.52 | 1 |
| GlaxoSmithKline, LLC. | $17.76 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $147.91 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104921428 | CMS |
| ABBVIE INC. | $30.44 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104921430 | CMS |
| ABBVIE INC. | $40.84 | 12/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104921432 | CMS |
| Blueprint Medicines Corporation | $2,156.00 | 03/15/2024 | Honoraria | Undisputed | 01/23/2026 | 1147447208 | CMS |
| Celgene Corporation | $115.00 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101080397 | CMS |
| Celgene Corporation | $31.41 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101080399 | CMS |
| E.R. Squibb & Sons, L.L.C. | $346.00 | 02/14/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101213820 | CMS |
| E.R. Squibb & Sons, L.L.C. | $2,499.00 | 09/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101213852 | CMS |
| GlaxoSmithKline, LLC. | $17.76 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115782641 | CMS |
| Rigel Pharmaceuticals, Inc. | $97.18 | 04/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145199807 | CMS |
| TAIHO ONCOLOGY, INC. | $2,340.00 | 01/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1137933999 | CMS |
| Tempus AI, Inc | $51.52 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150168930 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.